|
Shares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab biosimilars, Bosaya and Aukelso. The regulator also granted provisional interchangeability for both drugs, allowing pharmacy-level substitution, which could support broader market adoption and strengthen Biocons position in the biosimilars segment.
Category:
News and Media
Indian defence stocks are performing well in 2025. Apollo Micro Systems, Axiscades Technologies, and Sika Interplant Systems are top gainers. This surge reflects India's military modernization. A proposal to acquire Rafale fighter jets is under review. Experts suggest the rally may continue. The sector benefits from the government's indigenization push. The future of Indian defence is digital and networked.
Category:
News and Media
The event comes as Meta faces ongoing scrutiny over the impact of its products, particularly on children.
Category:
News and Media
All news |
||||||||||||||||||
|